Nope, bad idea. TSRX has little to no downside at this moment. The only "risk" is FDA approval which I don't see TRSX getting a CRL. Then there is Europe which is having an antibiotic crisis currently, which up's the value of TSRX for a partner in Europe or buyout for that matter.
Also, Cubist is losing patent on Cubicin which is 85% of their revenue (Ted combo fixes this problem) not to mention Pfizer is losing Zyvox rather soon and they have nothing to replace it with.. Bayer already has a large portion of the world, very deep pockets and might just pony up for Europe and/or the company as well.
Too much upside potential here as I see this as "risk free" currently for a small bio, which is rare.
However, GTXI will do very well IF they can get FDA approval (which is awhile out still).
I like your argument but tell me would you invest your entire portfolio in this one single stock? Being that it is risk free as you state why not put 100% of your investment into TSRX? That being said you and I very much know there is no such thing as risk free but I agree with your points. I just think GTXI will move in the short term much higher than TSRX but have no ill will towards anyone in TSRX and the kidding aside with Kitty I hope you TSRX peeps do great I just hope mine does better in GTXI.
GTXI market cap is slightly bigger than TSRX, and they have to finish trials (when will GTXI potentially file an NDA application?). Why would I sell TSRX to swap? I could buy GTXI, but not at the sacrifice of my TSRX position. I am not saying GTXI won't go higher I am simply saying I will stay with TSRX since they will be filing in several months and I like the odds.
High insider ownership, low float. Any news good or bad moves this in a big way i'm just banking on it being good. It's all a #$%$ shoot I just like my odds better with GTXI more so than TSRX as far as which stock will be more profitable to me.